| Name | Glucose Health, Inc. |
|---|---|
| CIK | 0001420108 |
| Tickers | GLUC |
| Exchanges | OTC |
| Entity type | operating |
| Category | Smaller reporting company |
| SIC | 2833 Medicinal Chemicals & Botanical Products |
| EIN | 901117742 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | 479-802-3827 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
No Financialist filing articles yet for this CIK.
140 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-10-19 | D | xslFormDX01/primary_doc.xml | 06b | 0001420108-26-000007 | 021-601719 | 261468587 | 33 | 9509 | ||
| 2026-10-07 | D | xslFormDX01/primary_doc.xml | 06b | 0001420108-26-000006 | 021-600381 | 261447753 | 33 | 9328 | ||
| 2026-10-06 | D | xslFormDX01/primary_doc.xml | 06b | 0001420108-26-000005 | 021-600102 | 261443627 | 33 | 9314 | ||
| 2026-10-06 | D | xslFormDX01/primary_doc.xml | 06b | 0001420108-26-000004 | 021-600098 | 261443586 | 33 | 9424 | ||
| 2026-09-10 | D | xslFormDX01/primary_doc.xml | 06b | 0001420108-26-000003 | 021-597074 | 261371856 | 33 | 9218 | ||
| 2026-07-07 | D | xslFormDX01/primary_doc.xml | 06b | 0001420108-26-000002 | 021-589791 | 261158925 | 33 | 8766 | ||
| 2026-02-04 | D | xslFormDX01/primary_doc.xml | 06b | 0001420108-26-000001 | 021-572404 | 26598651 | 33 | 8826 | ||
| 2025-12-05 | D | xslFormDX01/primary_doc.xml | 06b | 0001420108-25-000002 | 021-565982 | 251553539 | 33 | 9601 | ||
| 2024-01-19 | D/A | xslFormDX01/primary_doc.xml | 06b | 0001477932-24-000270 | 021-499069 | 24543484 | 33 | 5978 | ||
| 2023-12-07 | D | xslFormDX01/primary_doc.xml | 06b | 0001477932-23-009018 | 021-499069 | 231472095 | 33 | 5835 | ||
| 2023-06-28 | RW | RW | 0001477932-23-004855 | 333-265335 | 231051113 | NE | 8214 | |||
| 2023-01-09 | S-1/A | FORM S-1/A | 0001477932-23-000175 | 333-265335 | 23516481 | 33 | 7321643 | 1 | 1 | |
| 2022-09-06 | S-1/A | FORM S-1/A | 0001477932-22-006657 | 333-265335 | 221226632 | 33 | 6217257 | 1 | 1 | |
| 2022-08-05 | S-1/A | FORM S-1/A | 0001477932-22-005660 | 333-265335 | 221138525 | 33 | 5989452 | 1 | 1 | |
| 2022-06-01 | S-1 | FORM S-1 | 0001477932-22-004038 | 333-265335 | 22985362 | 33 | 18452087 | 1 | 1 | |
| 2021-03-09 | D | xslFormDX01/primary_doc.xml | 06b | 0001477932-21-001334 | 021-391678 | 21726235 | 33 | 7991 | ||
| 2020-06-19 | D | xslFormDX01/primary_doc.xml | 06b | 0001477932-20-003466 | 021-369359 | 20975498 | 33 | 7986 | ||
| 2020-05-12 | D | xslFormDX01/primary_doc.xml | 06b | 0001477932-20-002548 | 021-366749 | 20868685 | 33 | 5788 | ||
| 2019-05-03 | D | xslFormDX01/primary_doc.xml | 06b | 0001477932-19-002298 | 021-338746 | 19794426 | 33 | 5825 | ||
| 2018-04-16 | 15-12G | FORM 15-12G | 0001477932-18-001817 | 000-55439 | 18756653 | 34 | 6067 | |||
| 2018-04-02 | NT 10-K | NT 10-K | 0001477932-18-001620 | 000-55439 | 18728818 | 34 | 16271 | |||
| 2017-11-14 | 10-Q | FORM 10-Q | 0001477932-17-005517 | 000-55439 | 171198115 | 34 | 1542584 | 1 | ||
| 2017-08-21 | 10-Q | FORM 10-Q | 0001477932-17-004075 | 000-55439 | 171042080 | 34 | 1422895 | 1 | ||
| 2017-08-14 | NT 10-Q | NT 10-Q | 0001477932-17-003940 | 000-55439 | 171029989 | 34 | 18891 | |||
| 2017-05-15 | 10-Q | FORM 10-Q | 0001477932-17-002253 | 000-55439 | 17842566 | 34 | 1295072 | 1 | ||
| 2017-04-11 | 8-K | FORM 8-K | 4.01,9.01 | 0001477932-17-001658 | 000-55439 | 17755994 | 34 | 31290 | ||
| 2017-03-29 | 10-K | FORM 10-K | 0001477932-17-001354 | 000-55439 | 17720063 | 34 | 1945070 | 1 | ||
| 2016-12-21 | 10-Q | FORM 10-Q | 0001477932-16-014204 | 000-55439 | 162063657 | 34 | 1233006 | 1 | ||
| 2016-11-14 | NT 10-Q | NT 10-Q | 0001477932-16-013435 | 000-55439 | 161993614 | 34 | 20658 | |||
| 2016-08-22 | 10-Q | FORM 10-Q | 0001477932-16-012202 | 000-55439 | 161845992 | 34 | 1125760 | 1 | ||
| 2016-08-15 | NT 10-Q | NT 10-Q | 0001477932-16-011888 | 000-55439 | 161832462 | 34 | 18327 | |||
| 2016-05-23 | 10-Q | FORM 10-Q | 0001477932-16-010562 | 000-55439 | 161669279 | 34 | 1086027 | 1 | ||
| 2016-05-16 | NT 10-Q | NT 10-Q | 0001477932-16-010329 | 000-55439 | 161652131 | 34 | 17944 | |||
| 2016-04-14 | 10-K | FORM 10-K | 0001477932-16-009786 | 000-55439 | 161572553 | 34 | 2030843 | 1 | ||
| 2016-03-30 | NT 10-K | NT 10-K | 0001477932-16-009323 | 000-55439 | 161539528 | 34 | 18287 | |||
| 2016-03-11 | 8-K | FORM 8-K | 8.01 | 0001477932-16-009009 | 000-55439 | 161500705 | 34 | 11085 | ||
| 2016-02-05 | 8-K | FORM 8-K | 5.02 | 0001477932-16-008445 | 000-55439 | 161392497 | 34 | 11299 | ||
| 2016-01-27 | 8-K | FORM 8-K | 8.01 | 0001477932-16-008299 | 000-55439 | 161364068 | 34 | 10069 | ||
| 2015-11-23 | 10-Q | FORM 10-Q | 0001477932-15-007294 | 000-55439 | 151248224 | 34 | 1252684 | 1 | ||
| 2015-11-16 | NT 10-Q | NT 10-Q | 0001477932-15-006962 | 000-55439 | 151231464 | 34 | 19774 | |||
| 2015-08-18 | 10-Q | FORM 10-Q | 0001477932-15-005379 | 000-55439 | 151062219 | 34 | 1259748 | 1 | ||
| 2015-08-14 | NT 10-Q | NT 10-Q | 0001477932-15-005162 | 000-55439 | 151054284 | 34 | 20307 | |||
| 2015-08-06 | 8-K | FORM 8-K | 4.01,9.01 | 0001477932-15-004880 | 000-55439 | 151030396 | 34 | 33014 | ||
| 2015-05-19 | 10-Q | FORM 10-Q | 0001477932-15-003358 | 000-55439 | 15874698 | 34 | 1501488 | 1 | ||
| 2015-05-15 | NT 10-Q | NT 10-Q | 0001477932-15-003281 | 000-55439 | 15869338 | 34 | 19913 | |||
| 2015-05-08 | 3 | OWNERSHIP DOCUMENT FORM TYPE 3 | 0001554795-15-000171 | 4332 | ||||||
| 2015-05-01 | 8-A12G | 8-A12G | 0001477932-15-002847 | 000-55439 | 15823533 | 34 | 13073 | |||
| 2015-03-30 | 10-K | FORM 10-K | 0001477932-15-001981 | 333-147917 | 15734494 | 34 | 3072744 | 1 | ||
| 2015-02-12 | 8-K | FORM 8-K | 5.02 | 0001477932-15-001093 | 333-147917 | 15602470 | 34 | 10033 | ||
| 2014-12-16 | 8-K | FORM 8-K | 8.01,9.01 | 0001477932-14-007105 | 333-147917 | 141289752 | 34 | 16404 | ||
| 2014-11-10 | 8-K | FORM 8-K | 5.03,9.01 | 0001477932-14-005937 | 333-147917 | 141208992 | 34 | 1580247 | ||
| 2014-10-23 | 8-K/A | FORM 8-K/A | 1.01,3.02,5.01,5.02,9.01 | 0001477932-14-005595 | 333-147917 | 141168678 | 34 | 18746 | ||
| 2014-10-22 | 10-Q | FORM 10-Q | 0001477932-14-005534 | 333-147917 | 141166773 | 34 | 3165132 | 1 | ||
| 2014-10-07 | 8-K | FORM 8-K | 4.01,9.01 | 0001477932-14-005286 | 333-147917 | 141145239 | 34 | 39579 | ||
| 2014-10-02 | 8-K | FORM 8-K | 1.01,5.02,9.01 | 0001477932-14-005243 | 333-147917 | 141135680 | 34 | 44906 | ||
| 2014-08-12 | 10-Q | FORM 10-Q | 0001477932-14-004205 | 333-147917 | 141032892 | 34 | 3233700 | 1 | ||
| 2014-07-25 | 8-K | FORM 8-K | 5.02,9.01 | 0001477932-14-003877 | 333-147917 | 14992593 | 34 | 27685 | ||
| 2014-07-16 | 10-Q | FORM 10-Q | 0001477932-14-003731 | 333-147917 | 14977950 | 34 | 3484481 | 1 | ||
| 2014-07-01 | UPLOAD | filename1.pdf | 0000000000-14-033261 | 36594 | ||||||
| 2014-06-25 | 10-K | FORM 10-K | 0001477932-14-003318 | 333-147917 | 14940077 | 34 | 4642005 | 1 | ||
| 2014-05-05 | 8-K | FORM 8-K | 4.01,9.01 | 0001477932-14-002331 | 333-147917 | 14811262 | 34 | 51909 | ||
| 2014-05-05 | 10-K/A | FORM 10-K/A | 0001477932-14-002329 | 333-147917 | 14811258 | 34 | 3008074 | 1 | ||
| 2014-04-24 | 10-K/A | FORM 10-K/A | 0001477932-14-001939 | 333-147917 | 14781543 | 34 | 1244252 | |||
| 2014-04-23 | 8-K | FORM 8-K | 5.02 | 0001477932-14-001911 | 333-147917 | 14777387 | 34 | 21791 | ||
| 2014-04-15 | 8-K | FORM 8-K | 1.01,1.02,5.02,5.03,9.01 | 0001477932-14-001755 | 333-147917 | 14763990 | 34 | 6037173 | ||
| 2014-03-31 | NT 10-K | NT 10-K | 0001477932-14-001340 | 333-147917 | 14727743 | 34 | 40900 | |||
| 2014-03-19 | CORRESP | filename1.htm | 0001477932-14-001135 | 118845 | ||||||
| 2014-03-06 | UPLOAD | filename1.pdf | 0000000000-14-011340 | 43232 | ||||||
| 2014-02-25 | CORRESP | filename1.htm | 0001477932-14-000843 | 834919 | ||||||
| 2014-01-28 | CORRESP | filename1.htm | 0001477932-14-000404 | 24621 | ||||||
| 2014-01-14 | UPLOAD | filename1.pdf | 0000000000-14-001876 | 164238 | ||||||
| 2014-01-02 | CORRESP | filename1.htm | 0001477932-14-000004 | 587521 | ||||||
| 2013-12-18 | UPLOAD | filename1.pdf | 0000000000-13-068591 | 164474 | ||||||
| 2013-12-04 | CORRESP | filename1.htm | 0001477932-13-005930 | 270091 | ||||||
| 2013-11-20 | UPLOAD | filename1.pdf | 0000000000-13-063739 | 167430 | ||||||
| 2013-11-14 | 10-Q | FORM 10-Q | 0001477932-13-005415 | 333-147917 | 131216712 | 34 | 2268969 | 1 | ||
| 2013-08-06 | 8-K | FORM 8-K | 1.01,9.01 | 0001477932-13-003492 | 333-147917 | 131012988 | 34 | 3798012 | ||
| 2013-08-02 | 10-Q | FORM 10-Q | 0001477932-13-003445 | 333-147917 | 131004804 | 34 | 3308759 | 1 | ||
| 2013-05-06 | 10-Q | FORM 10-Q | 0001477932-13-002137 | 333-147917 | 13814576 | 34 | 1784968 | 1 | ||
| 2013-03-22 | 10-K | FORM 10-K | 0001477932-13-001273 | 333-147917 | 13709899 | 34 | 3133731 | 1 | ||
| 2013-03-04 | S-8 | BIO-SOLUTIONS CORP. FORM S-8 | 0001566506-13-000012 | 333-187038 | 13662747 | 33 | 236962 | |||
| 2012-11-14 | 10-Q | bisu10q930.htm | 0001471242-12-001449 | 333-147917 | 121203106 | 34 | 2126681 | 1 | ||
| 2012-09-05 | 10-Q/A | bio-solutions10qa063012.htm | 0001432093-12-000697 | 333-147917 | 121072971 | 34 | 56226 | |||
| 2012-08-31 | 10-Q/A | biosolutions10qa063012.htm | 0001432093-12-000689 | 333-147917 | 121068325 | 34 | 1672006 | 1 | ||
| 2012-08-13 | 10-Q | biosolutions10q063012.htm | 0001432093-12-000611 | 333-147917 | 121027017 | 34 | 524970 | |||
| 2012-07-25 | 10-Q | bio-solutions10q033112.htm | 0001432093-12-000578 | 333-147917 | 12978055 | 34 | 1528054 | 1 | ||
| 2012-06-26 | 8-K | bio-solutions8k062012.htm | 5.02,9.01 | 0001432093-12-000499 | 333-147917 | 12925553 | 34 | 26133 | ||
| 2012-05-31 | 10-K | bio-solutions10k123111.htm | 0001214782-12-000044 | 333-147917 | 12880473 | 34 | 2286161 | 1 | ||
| 2012-03-29 | NT 10-K | bio-solutionsnt10k123111.htm | 0001432093-12-000188 | 333-147917 | 12723927 | 34 | 24820 | |||
| 2012-02-27 | 8-K | biosolutions8k021512.htm | 5.02,9.01 | 0001214782-12-000015 | 333-147917 | 12641079 | 34 | 26261 | ||
| 2011-11-22 | 8-K | BIO-SOLUTIONS, CORP. FORM 8-K FOR SEPTEMBER 26, 2011 | 1.01,2.01,9.01 | 0001214782-11-000198 | 333-147917 | 111220351 | 34 | 917263 | ||
| 2011-11-21 | 10-Q | biosolutions10q093011.htm | 0001214782-11-000191 | 333-147917 | 111218026 | 34 | 1446917 | 1 | ||
| 2011-11-16 | 8-K | biosolutiions8k101011.htm | 5.02,9.01 | 0001214782-11-000184 | 333-147917 | 111208896 | 34 | 30886 | ||
| 2011-11-14 | NT 10-Q | bio-solutionsnt10q093011.htm | 0001214782-11-000167 | 333-147917 | 111198557 | 34 | 25070 | |||
| 2011-10-27 | UPLOAD | filename1.pdf | 0000000000-11-062774 | 45414 | ||||||
| 2011-09-29 | 10-K/A | f12312010kafinal.htm | 0001096350-11-000147 | 333-147917 | 111113050 | 34 | 471300 | |||
| 2011-09-28 | CORRESP | filename1.htm | 0001096350-11-000148 | 8530 | ||||||
| 2011-09-28 | 10-Q/A | tenqa.htm | 0001096350-11-000145 | 333-147917 | 111112963 | 34 | 1017780 | 1 | ||
| 2011-09-20 | UPLOAD | filename1.pdf | 0000000000-11-055885 | 59154 | ||||||
| 2011-08-22 | 10-Q | tenq.htm | 0001096350-11-000114 | 333-147917 | 111049594 | 34 | 218775 | |||
| 2011-08-12 | NT 10-Q | form12b25_extension.htm | 0001096350-11-000111 | 333-147917 | 111032076 | 34 | 14576 | |||
| 2011-05-23 | 10-Q | tenq.htm | 0001096350-11-000083 | 333-147917 | 11865271 | 34 | 305771 | |||
| 2011-05-23 | 10-Q | tenq.htm | 0001096350-11-000082 | 333-147917 | 11865037 | 34 | 305771 | |||
| 2011-05-16 | NT 10-Q | late.htm | 0001096350-11-000075 | 333-147917 | 11844020 | 34 | 14027 | |||
| 2011-04-20 | 10-K/A | tenka.htm | 0001096350-11-000067 | 333-147917 | 11769862 | 34 | 450252 | |||
| 2011-04-14 | 10-K | f12312010k.htm | 0001096350-11-000063 | 333-147917 | 11759805 | 34 | 429947 | |||
| 2011-03-31 | NT 10-K | late.htm | 0001096350-11-000060 | 333-147917 | 11725081 | 34 | 13819 | |||
| 2011-03-29 | S-8 | s8.htm | 0001096350-11-000057 | 333-173152 | 11719618 | 33 | 159120 | |||
| 2010-11-22 | 10-Q | QUARTERLY REPORT ON FORM 10-Q | 0001469299-10-000355 | 333-147917 | 101209454 | 34 | 492070 | |||
| 2010-11-15 | NT 10-Q | BIO-SOLUTIONS FORM 12B25 093010 | 0001469299-10-000346 | 333-147917 | 101192522 | 34 | 34815 | |||
| 2010-08-13 | 10-Q | BIO-SOLUTIONS FORM 10-Q 063010 | 0001469299-10-000238 | 333-147917 | 101014688 | 34 | 494707 | |||
| 2010-06-25 | 8-K | BIO-SOLUTIONS FORM 8-K 06/25/10 | 7.01,8.01,9.01 | 0001469299-10-000188 | 333-147917 | 10917726 | 34 | 123310 | ||
| 2010-05-17 | 10-Q | BIO-SOLUTIONS FORM 10-Q 03/31/10 | 0001469299-10-000163 | 333-147917 | 10838304 | 34 | 448278 | |||
| 2010-04-15 | 10-K | BIO-SOLUTIONS FORM 10-K 123109 | 0001469299-10-000114 | 333-147917 | 10753012 | 34 | 789401 | |||
| 2010-03-31 | NT 10-K | BIO-SOLUTIONS FORM 12B25 12/31/09 | 0001469299-10-000089 | 333-147917 | 10718858 | 34 | 29978 | |||
| 2009-11-16 | 10-Q | BIO-SOL FORM 10Q 09/30/09 | 0001469299-09-000040 | 333-147917 | 091186011 | 34 | 449217 | |||
| 2009-08-18 | 8-K | BIO-SOLUTIONS FORM 8-K 081709 | 1.01 | 0001469299-09-000019 | 333-147917 | 091021764 | 34 | 106466 | ||
| 2009-08-14 | 10-Q | BIO-SOLUTIONS FORM10-Q 063009 | 0001469299-09-000015 | 333-147917 | 091014124 | 34 | 508260 | |||
| 2009-05-14 | 10-Q | BIO SOLUTIONS FORM 10-Q 033109 | 0001402973-09-000048 | 333-147917 | 09827621 | 34 | 453651 | |||
| 2009-05-12 | 424B3 | BIO SOLUTIONS FORM 424B3 051109 | 0001402973-09-000042 | 333-158129 | 09818990 | 33 | 810781 | |||
| 2009-05-06 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2009-05-06 16:00:00 | 9999999995-09-001316 | 333-158129 | 09803346 | 33 | 2079 | ||
| 2009-05-04 | CORRESP | filename1.htm | 0001402973-09-000038 | 11419 | ||||||
| 2009-04-24 | UPLOAD | filename1.pdf | 0000000000-09-021815 | 72564 | ||||||
| 2009-04-23 | CORRESP | filename1.htm | 0001402973-09-000036 | 23246 | ||||||
| 2009-04-23 | S-1/A | BIO SOLUTIONS FORM S-1/A 042209 | 0001402973-09-000035 | 333-158129 | 09766062 | 33 | 856885 | |||
| 2009-04-23 | 10-K/A | BIO SOLUTIONS FORM 10-K/A 12/31/08 | 0001402973-09-000034 | 333-147917 | 09766059 | 34 | 98233 | |||
| 2009-03-20 | S-1 | BIO SOLUTIONS FORM S-1 031809 | 0001402973-09-000020 | 333-158129 | 09696900 | 33 | 855046 | |||
| 2009-03-18 | 8-K | BIO SOLUTIONS FORM 8-K 031709 | 5.02,9.01 | 0001402973-09-000013 | 333-147917 | 09691690 | 34 | 28837 | ||
| 2009-03-16 | 10-K | BIO-SOLUTIONS FORM 10-K FOR THE PERIOD DECEMBER 31, 2008 | 0001402973-09-000011 | 333-147917 | 09683546 | 34 | 780667 | |||
| 2008-12-23 | 8-K | BIO SOLUTIONS FORM 8-K 121808 | 3.02 | 0001402973-08-000081 | 333-147917 | 081267543 | 34 | 25853 | ||
| 2008-11-14 | 10-Q | BIO SOLUTIONS FORM 10Q 093008 | 0001402973-08-000064 | 333-147917 | 081191992 | 34 | 483263 | |||
| 2008-09-16 | 8-K | BIO-SOL CORP FORM 8-K 090308 | 1.01,2.03,5.06,9.01 | 0001402973-08-000059 | 333-147917 | 081074789 | 34 | 156904 | ||
| 2008-08-13 | 10-Q | BIO-SOLUTIONS CORP. FORM 10-Q FOR THE PERIOD JUNE, 30 2008 | 0001402973-08-000052 | 333-147917 | 081013277 | 34 | 462288 | |||
| 2008-05-09 | 10-Q | BIO-SOLUTIONS CORP. FORM 10-Q FOR THE PERIOD ENDING MARCH 31, 2008 | 0001402973-08-000037 | 333-147917 | 08815476 | 34 | 411871 | |||
| 2008-04-10 | 10KSB | BIO-SOLUTIONS FORM 10-KSB FOR THE PERIOD DECEMBER 31, 2007 | 0001402973-08-000033 | 333-147917 | 08750218 | 34 | 534350 | |||
| 2008-04-01 | NT 10-K | BIO-SOLUTIONS CORP. FORM NT 10-K FOR THE PERIOD 12/31/07 | 0001402973-08-000031 | 333-147917 | 08728393 | 34 | 52785 | |||
| 2008-02-01 | 8-K | BIO-SOLUTIONS CORP. FORM 8-K JANUARY 29, 2008 | 4.01,9.01 | 0001402973-08-000018 | 333-147917 | 08565916 | 34 | 43055 | ||
| 2007-12-28 | 424B3 | BIO-SOLUTIONS CORP. 424(B)(3) DECEMBER 26, 2007 | 0001402973-07-000031 | 333-147917 | 071331500 | 33 | 783982 | |||
| 2007-12-21 | EFFECT | xslEFFECTX01/primary_doc.xml | SB-2,,2007-12-21 14:00:00 | 9999999995-07-005068 | 333-147917 | 071324772 | 33 | 2081 | ||
| 2007-12-07 | SB-2 | BIO-SOLUTIONS CORP. FORM SB-2 | 0001402973-07-000026 | 333-147917 | 071291327 | 33 | 1003004 |
One latest value per concept from companyfacts (160 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 4.55M | 2017-11-14 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 78,485 | 2016-06-30 | 2016 | FY | 10-K | 2017-03-29 | 0001477932-17-001354 | |
| us-gaap | AccountsPayable | Accounts Payable (Deprecated 2009-01-31) | USD | 384,509 | 2010-12-31 | 2011 | Q2 | 10-Q/A | 2011-09-28 | 0001096350-11-000145 | |
| us-gaap | AccountsPayableAndAccruedLiabilitiesCurrent | Accounts Payable and Accrued Liabilities, Current | USD | 78,279 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 | |
| us-gaap | AccountsReceivableNetCurrent | Accounts Receivable, after Allowance for Credit Loss, Current | USD | 9,105 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 | |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 41,429 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 | |
| us-gaap | AccumulatedAmortizationOfNoncurrentDeferredFinanceCosts | Accumulated Amortization, Debt Issuance Costs, Noncurrent | USD | 105 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossBeforeTax | Accumulated Other Comprehensive Income (Loss), before Tax (Deprecated 2009-01-31) | USD | -68,019 | 2010-12-31 | 2011 | Q2 | 10-Q/A | 2011-09-28 | 0001096350-11-000145 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -75,278 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 120,000 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-29 | 0001477932-17-001354 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 5.72M | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 | |
| us-gaap | AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities | Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities | USD | -52,924 | 2017-01-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalOther | Adjustments to Additional Paid in Capital, Other | USD | 73,748 | 2011-10-01 | 2011-12-31 | 2011 | FY | 10-K | 2012-05-31 | 0001214782-12-000044 |
| us-gaap | AdvertisingExpense | Advertising Expense | USD | 5,437 | 2017-01-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 |
| us-gaap | AmortizationExpensePerDollarOfGrossRevenue | Amortization Expense Per Dollar of Gross Revenue | USD | 24,167 | 2010-06-30 | 2011 | Q2 | 10-Q/A | 2011-09-28 | 0001096350-11-000145 | |
| us-gaap | AmortizationOfDebtDiscountPremium | Amortization of Debt Discount (Premium) | USD | 201,902 | 2016-01-01 | 2016-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 |
| us-gaap | AmortizationOfIntangibleAssets | Amortization of Intangible Assets | USD | 45 | 2017-01-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 |
| us-gaap | AssetImpairmentCharges | Asset Impairment Charges | USD | 200,000 | 2013-01-01 | 2013-12-31 | 2014 | FY | 10-K | 2015-03-30 | 0001477932-15-001981 |
| us-gaap | Assets | Assets | USD | 26,353 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 26,158 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 | |
| us-gaap | Cash | Cash | USD | 23,639 | 2016-09-30 | 2016 | Q3 | 10-Q | 2016-12-21 | 0001477932-16-014204 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 16,636 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 | |
| us-gaap | CashAndCashEquivalentsPeriodIncreaseDecrease | Cash and Cash Equivalents, Period Increase (Decrease) | USD | -3,906 | 2017-01-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 |
| us-gaap | CashEquivalentsAtCarryingValue | Cash Equivalents, at Carrying Value | USD | 16,636 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 | |
| us-gaap | CommonStockAdditionalSeriesSharesAuthorized | Common Stock, Additional Series, Shares Authorized (Deprecated 2009-01-31) | shares | 90.00M | 2010-06-30 | 2012 | FY | 10-K | 2013-03-22 | 0001477932-13-001273 | |
| us-gaap | CommonStockAdditionalSeriesSharesIssued | Common Stock, Additional Series, Shares, Issued (Deprecated 2009-01-31) | shares | 251,050 | 2010-06-30 | 2011 | Q2 | 10-Q/A | 2011-09-28 | 0001096350-11-000145 | |
| us-gaap | CommonStockNoParValue | Common Stock, No Par Value | USD/shares | 0.015 | 2013-06-18 | 2013 | Q3 | 10-Q | 2013-11-14 | 0001477932-13-005415 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0.001 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 200.00M | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 4.52M | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 4.52M | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 | |
| us-gaap | CommonStockSharesSubscriptions | Common Stock, Value, Subscriptions | USD | 23,000 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 | |
| us-gaap | CommonStockShareSubscribedButUnissuedSubscriptionsReceivable | Common Stock, Share Subscribed but Unissued, Subscriptions Receivable | USD | 1,520 | 2011-09-30 | 2011 | Q3 | 10-Q | 2011-11-21 | 0001214782-11-000191 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 4,516 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -2.09M | 2011-10-01 | 2014-03-31 | 2014 | Q1 | 10-Q | 2014-07-16 | 0001477932-14-003731 |
| us-gaap | ConvertibleNotesPayable | Convertible Notes Payable | USD | 159,220 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 | |
| us-gaap | ConvertibleNotesPayableCurrent | Convertible Notes Payable, Current | USD | 112,157 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 | |
| us-gaap | CostOfGoodsAndServicesSold | Cost of Goods and Services Sold | USD | 279,258 | 2016-01-01 | 2016-09-30 | 2016 | Q3 | 10-Q | 2016-12-21 | 0001477932-16-014204 |
| us-gaap | CostOfGoodsSold | Cost of Goods Sold (Deprecated 2018-01-31) | USD | 3,632 | 2011-10-01 | 2012-12-31 | 2012 | FY | 10-K/A | 2014-05-05 | 0001477932-14-002329 |
| us-gaap | CostOfRevenue | Cost of Revenue | USD | 15,700 | 2017-01-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 |
| us-gaap | DebtConversionConvertedInstrumentAmount1 | Debt Conversion, Converted Instrument, Amount | USD | 29,291 | 2017-01-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 |
| us-gaap | DebtConversionOriginalDebtAmount1 | Debt Conversion, Original Debt, Amount | USD | -10,436 | 2015-01-01 | 2015-12-31 | 2016 | FY | 10-K | 2017-03-29 | 0001477932-17-001354 |
| us-gaap | DebtCurrent | Debt, Current | USD | 169,923 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-30 | 0001477932-15-001981 | |
| us-gaap | DebtInstrumentConvertibleBeneficialConversionFeature | Debt Instrument, Convertible, Beneficial Conversion Feature | USD | 109,541 | 2015-01-01 | 2015-12-31 | 2016 | FY | 10-K | 2017-03-29 | 0001477932-17-001354 |
| us-gaap | DebtInstrumentConvertibleConversionPrice1 | Debt Instrument, Convertible, Conversion Price | USD/shares | 0.007 | 2012-07-31 | 2012 | Q2 | 10-Q/A | 2012-08-31 | 0001432093-12-000689 | |
| us-gaap | DebtInstrumentConvertibleNumberOfEquityInstruments | Debt Instrument, Convertible, Number of Equity Instruments | shares | 14.53M | 2012-01-01 | 2012-09-30 | 2012 | Q3 | 10-Q | 2012-11-14 | 0001471242-12-001449 |
| us-gaap | DebtInstrumentFaceAmount | Debt Instrument, Face Amount | USD | 30,000 | 2012-07-31 | 2012 | Q2 | 10-Q/A | 2012-08-31 | 0001432093-12-000689 | |
| us-gaap | DebtInstrumentFairValue | Debt Instrument, Fair Value Disclosure | USD | 0 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 | |
| us-gaap | DebtInstrumentInterestRateStatedPercentage | Debt Instrument, Interest Rate, Stated Percentage | pure | 0.05 | 2012-12-31 | 2012 | FY | 10-K/A | 2014-05-05 | 0001477932-14-002329 | |
| us-gaap | DeferredCompensationLiabilityCurrent | Deferred Compensation Liability, Current | USD | -17,372 | 2013-12-31 | 2014 | FY | 10-K | 2015-03-30 | 0001477932-15-001981 | |
| us-gaap | DeferredFederalIncomeTaxExpenseBenefit | Deferred Federal Income Tax Expense (Benefit) | USD | -2.06M | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-29 | 0001477932-17-001354 |
| us-gaap | DeferredStateAndLocalIncomeTaxExpenseBenefit | Deferred State and Local Income Tax Expense (Benefit) | USD | -2.06M | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-29 | 0001477932-17-001354 |
| us-gaap | DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage | Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) | USD | 2.07M | 2014-03-31 | 2014 | Q1 | 10-Q | 2014-07-16 | 0001477932-14-003731 | |
| us-gaap | DueFromAffiliates | Due from Affiliates | USD | 250 | 2015-12-31 | 2016 | FY | 10-K | 2017-03-29 | 0001477932-17-001354 | |
| us-gaap | DueToOfficersOrStockholders | Due to Officers or Stockholders (Deprecated 2009-01-31) | USD | 4,858 | 2010-12-31 | 2011 | Q2 | 10-Q/A | 2011-09-28 | 0001096350-11-000145 | |
| us-gaap | DueToOfficersOrStockholdersCurrent | Due to Officers or Stockholders, Current | USD | 4,751 | 2011-12-31 | 2012 | FY | 10-K/A | 2014-05-05 | 0001477932-14-002329 | |
| us-gaap | DueToOtherRelatedPartiesClassifiedCurrent | Due to Other Related Parties, Current | USD | 9,000 | 2012-09-30 | 2012 | Q3 | 10-Q | 2012-11-14 | 0001471242-12-001449 | |
| us-gaap | DueToRelatedPartiesCurrent | Due to Related Parties, Current | USD | 1,672 | 2013-12-31 | 2014 | FY | 10-K | 2015-03-30 | 0001477932-15-001981 | |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | 0.01 | 2017-01-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | -0.34 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-29 | 0001477932-17-001354 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | 0 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-29 | 0001477932-17-001354 |
| us-gaap | EffectOfExchangeRateOnCashAndCashEquivalents | Effect of Exchange Rate on Cash and Cash Equivalents | USD | 5,507 | 2011-10-01 | 2014-03-31 | 2014 | Q1 | 10-Q | 2014-07-16 | 0001477932-14-003731 |
| us-gaap | FairValueAssumptionsExpectedVolatilityRate | Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) | pure | 1.971 | 2014-01-01 | 2014-12-31 | 2015 | FY | 10-K | 2016-04-14 | 0001477932-16-009786 |
| us-gaap | FairValueAssumptionsRiskFreeInterestRate | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) | pure | 0.009 | 2014-01-01 | 2014-12-31 | 2015 | FY | 10-K | 2016-04-14 | 0001477932-16-009786 |
| us-gaap | FiniteLivedIntangibleAssetsAcquired | Finite-lived Intangible Assets Acquired (Deprecated 2013-01-31) | USD | 141,525 | 2008-09-11 | 2011-09-11 | 2012 | Q3 | 10-Q | 2012-11-14 | 0001471242-12-001449 |
| us-gaap | GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness | Gain (Loss) on Components Excluded from Assessment of Foreign Currency Cash Flow Hedge Effectiveness | USD | -807 | 2011-01-30 | 2011-06-30 | 2011 | Q2 | 10-Q/A | 2011-09-28 | 0001096350-11-000145 |
| us-gaap | GainLossOnNonRecourseDebt | Gain (Loss) on Non-Recourse Debt | USD | 14,562 | 2014-01-01 | 2014-12-31 | 2015 | FY | 10-K | 2016-04-14 | 0001477932-16-009786 |
| us-gaap | GainsLossesOnExtinguishmentOfDebt | Gain (Loss) on Extinguishment of Debt | USD | -21,000 | 2013-01-01 | 2013-09-30 | 2014 | Q3 | 10-Q | 2014-10-22 | 0001477932-14-005534 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 24,741 | 2017-01-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 |
| us-gaap | GrossProfit | Gross Profit | USD | 57,240 | 2017-01-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 |
| us-gaap | GroundLeasesAccumulatedAmortization | Ground Leases, Accumulated Amortization | USD | 75 | 2017-03-31 | 2017 | Q1 | 10-Q | 2017-05-15 | 0001477932-17-002253 | |
| us-gaap | ImpairedFinancingReceivableUnpaidPrincipalBalance | Impaired Financing Receivable, Unpaid Principal Balance | USD | 6,000 | 2013-12-31 | 2013 | FY | 10-K | 2014-06-25 | 0001477932-14-003318 | |
| us-gaap | ImpairmentChargeOnReclassifiedAssets | Impairment Charge on Reclassified Assets | USD | 20,829 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-30 | 0001477932-15-001981 |
| us-gaap | ImpairmentOfIntangibleAssetsFinitelived | Impairment of Intangible Assets, Finite-lived | USD | 34,967 | 2010-01-01 | 2010-12-31 | 2012 | Q3 | 10-Q | 2012-11-14 | 0001471242-12-001449 |
| us-gaap | ImpairmentOfInvestments | Other than Temporary Impairment Losses, Investments | USD | 200,000 | 2013-01-01 | 2013-12-31 | 2014 | FY | 10-K | 2015-03-30 | 0001477932-15-001981 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | 39,018 | 2017-01-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | -58,131 | 2017-01-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 |
| us-gaap | IncreaseDecreaseInAccountsPayableAndAccruedLiabilities | Increase (Decrease) in Accounts Payable and Accrued Liabilities | USD | 1,416 | 2017-01-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 |
| us-gaap | IncreaseDecreaseInAccountsReceivable | Increase (Decrease) in Accounts Receivable | USD | -221 | 2017-01-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 |
| us-gaap | IncreaseDecreaseInInventories | Increase (Decrease) in Inventories | USD | -1,952 | 2016-01-01 | 2016-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 |
| us-gaap | IncreaseDecreaseInInventoryForLongTermContractsOrPrograms | Increase (Decrease) in Inventory for Long-term Contracts or Programs | USD | -4,125 | 2010-01-30 | 2010-06-30 | 2011 | Q2 | 10-Q/A | 2011-09-28 | 0001096350-11-000145 |
| us-gaap | IncreaseDecreaseInPrepaidExpense | Increase (Decrease) in Prepaid Expense | USD | 531 | 2017-01-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 |
| us-gaap | IndefiniteLivedIntangibleAssetsExcludingGoodwill | Indefinite-lived Intangible Assets (Excluding Goodwill) | USD | 195 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 | |
| us-gaap | InterestExpense | Interest Expense | USD | 11,512 | 2017-01-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 |
| us-gaap | InterestPaid | Interest Paid, Including Capitalized Interest, Operating and Investing Activities | USD | 1,499 | 2010-01-01 | 2010-09-30 | 2011 | Q3 | 10-Q | 2011-11-21 | 0001214782-11-000191 |
| us-gaap | InterestPayableCurrent | Interest Payable, Current | USD | 33,081 | 2016-09-30 | 2016 | Q3 | 10-Q | 2016-12-21 | 0001477932-16-014204 | |
| us-gaap | InventoryFinishedGoods | Inventory, Finished Goods, Gross | USD | 87,758 | 2010-12-31 | 2012 | FY | 10-K/A | 2014-05-05 | 0001477932-14-002329 | |
| us-gaap | InventoryNet | Inventory, Net | USD | 0 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 | |
| us-gaap | InventoryWriteDown | Inventory Write-down | USD | 14,402 | 2014-01-01 | 2014-12-31 | 2015 | FY | 10-K | 2016-04-14 | 0001477932-16-009786 |
| us-gaap | IssuanceOfStockAndWarrantsForServicesOrClaims | Issuance of Stock and Warrants for Services or Claims | USD | 1,875 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-29 | 0001477932-17-001354 |
| us-gaap | LeaseAndRentalExpense | Operating Leases, Rent Expense | USD | 0 | 2012-01-01 | 2012-12-31 | 2012 | FY | 10-K/A | 2014-05-05 | 0001477932-14-002329 |
| us-gaap | Liabilities | Liabilities | USD | 452,585 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 26,353 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 452,585 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 10,000 | 2017-01-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | 250 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-29 | 0001477932-17-001354 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -13,906 | 2017-01-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | 39,018 | 2017-01-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | 46,619 | 2017-01-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 |
| us-gaap | NotesIssued1 | Notes Issued | USD | 294,722 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-29 | 0001477932-17-001354 |
| us-gaap | NotesPayableCurrent | Notes Payable, Current | USD | 10,000 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 | |
| us-gaap | NotesPayableRelatedPartiesClassifiedCurrent | Notes Payable, Related Parties, Current | USD | 35,000 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 | |
| us-gaap | NumberOfReportingUnits | Number of Reporting Units | Unit | 4,927 | 2017-01-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 64,841 | 2017-01-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -7,601 | 2017-01-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 |
| us-gaap | OperatingLossCarryforwards | Operating Loss Carryforwards | USD | 6.24M | 2016-12-31 | 2016 | FY | 10-K | 2017-03-29 | 0001477932-17-001354 | |
| us-gaap | OtherAssetImpairmentCharges | Other Asset Impairment Charges | USD | 200,000 | 2013-01-01 | 2013-12-31 | 2014 | Q3 | 10-Q | 2014-10-22 | 0001477932-14-005534 |
| us-gaap | OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax | USD | -12,578 | 2011-10-01 | 2014-03-31 | 2014 | Q1 | 10-Q | 2014-07-16 | 0001477932-14-003731 |
| us-gaap | OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss), before Reclassification and Tax | USD | 0 | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-06-25 | 0001477932-14-003318 |
| us-gaap | OtherExpenses | Other Expenses | USD | -10,537 | 2011-01-31 | 2011-06-30 | 2011 | Q2 | 10-Q/A | 2011-09-28 | 0001096350-11-000145 |
| us-gaap | OtherIntangibleAssetsNet | Other Intangible Assets, Net | USD | 200,000 | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-10-22 | 0001477932-14-005534 | |
| us-gaap | OtherNoncashIncome | Other Noncash Income | USD | 20,573 | 2015-01-01 | 2015-09-30 | 2016 | Q3 | 10-Q | 2016-12-21 | 0001477932-16-014204 |
| us-gaap | OtherNotesPayableCurrent | Other Notes Payable, Current | USD | 16,500 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 | |
| us-gaap | OtherSalesRevenueNet | Other Revenue, Net (Deprecated 2018-01-31) | USD | 20,829 | 2014-01-01 | 2014-12-31 | 2015 | FY | 10-K | 2016-04-14 | 0001477932-16-009786 |
| us-gaap | OtherSignificantNoncashTransactionValueOfConsiderationGiven1 | Other Significant Noncash Transaction, Value of Consideration Given | USD | 291,559 | 2011-10-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-06-25 | 0001477932-14-003318 |
| us-gaap | PaymentsForAdvanceToAffiliate | Payments for Advance to Affiliate | USD | 250 | 2015-01-01 | 2015-09-30 | 2016 | Q3 | 10-Q | 2016-12-21 | 0001477932-16-014204 |
| us-gaap | PaymentsToAcquireIntangibleAssets | Payments to Acquire Intangible Assets | CAD | 50,000 | 2008-09-11 | 2011-09-11 | 2012 | Q3 | 10-Q | 2012-11-14 | 0001471242-12-001449 |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 1,000 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 1,000 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 1,000 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 113,200 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 | |
| us-gaap | PrepaidExpenseCurrent | Prepaid Expense, Current | USD | 417 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 | |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 11,480 | 2011-01-01 | 2011-12-31 | 2012 | FY | 10-K/A | 2014-05-05 | 0001477932-14-002329 |
| us-gaap | ProceedsFromNotesPayable | Proceeds from Notes Payable | USD | 33,500 | 2017-01-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 |
| us-gaap | ProceedsFromRepaymentsOfOtherDebt | Proceeds from (Repayments of) Other Debt | USD | 76,850 | 2011-10-01 | 2012-12-31 | 2012 | FY | 10-K/A | 2014-05-05 | 0001477932-14-002329 |
| us-gaap | ProceedsFromRepaymentsOfShortTermDebt | Proceeds from (Repayments of) Short-term Debt | USD | -1,387 | 2011-10-01 | 2012-12-31 | 2012 | FY | 10-K/A | 2014-05-05 | 0001477932-14-002329 |
| us-gaap | ProductionRelatedImpairmentsOrCharges | Production Related Impairments or Charges | USD | 200,000 | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-06-25 | 0001477932-14-003318 |
| us-gaap | ProfessionalFees | Professional Fees | USD | 39,194 | 2017-01-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -1.46M | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-06-25 | 0001477932-14-003318 |
| us-gaap | PropertyPlantAndEquipmentSalvageValue | Property, Plant, and Equipment, Salvage Value | USD | 225 | 2017-03-31 | 2017 | Q1 | 10-Q | 2017-05-15 | 0001477932-17-002253 | |
| us-gaap | RepaymentsOfNotesPayable | Repayments of Notes Payable | USD | 23,500 | 2017-01-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 48 | 2015-01-01 | 2015-12-31 | 2016 | FY | 10-K | 2017-03-29 | 0001477932-17-001354 |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -6.21M | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 | |
| us-gaap | SalariesAndWages | Salary and Wage, NonOfficer, Excluding Cost of Good and Service Sold | USD | 504,192 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-30 | 0001477932-15-001981 |
| us-gaap | SaleLeasebackTransactionHistoricalCost | Sale Leaseback Transaction, Historical Cost | USD | 300 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 | |
| us-gaap | SaleOfStockPricePerShare | Sale of Stock, Price Per Share | USD/shares | 0.018 | 2013-12-31 | 2014 | Q3 | 10-Q | 2014-10-22 | 0001477932-14-005534 | |
| us-gaap | SalesRevenueGoodsNet | Sales Revenue, Goods, Net (Deprecated 2018-01-31) | USD | 72,940 | 2017-01-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 906 | 2017-01-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized | Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized | shares | 20.00M | 2011-03-31 | 2012 | Q2 | 10-Q/A | 2012-08-31 | 0001432093-12-000689 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period | shares | 15.47M | 2011-03-01 | 2011-03-31 | 2012 | Q2 | 10-Q/A | 2012-08-31 | 0001432093-12-000689 |
| us-gaap | SharePrice | Share Price | USD/shares | 0.006 | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-10-22 | 0001477932-14-005534 | |
| us-gaap | ShortTermBankLoansAndNotesPayable | Short-term Bank Loans and Notes Payable | USD | 145,783 | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-10-22 | 0001477932-14-005534 | |
| us-gaap | ShortTermBorrowings | Short-term Debt | USD | 49,227 | 2010-12-31 | 2011 | Q2 | 10-Q/A | 2011-09-28 | 0001096350-11-000145 | |
| us-gaap | ShortTermDebtPercentageBearingFixedInterestRate | Short-term Debt, Percentage Bearing Fixed Interest Rate | pure | 0.05 | 2013-09-30 | 2013 | Q3 | 10-Q | 2013-11-14 | 0001477932-13-005415 | |
| us-gaap | ShortTermNonBankLoansAndNotesPayable | Short-term Non-bank Loans and Notes Payable | USD | 91,716 | 2013-09-30 | 2013 | Q3 | 10-Q | 2013-11-14 | 0001477932-13-005415 | |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | -426,232 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 | |
| us-gaap | StockIssued1 | Stock Issued | USD | 4,315 | 2015-01-01 | 2015-12-31 | 2016 | FY | 10-K | 2017-03-29 | 0001477932-17-001354 |
| us-gaap | StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities | Stock Issued During Period, Shares, Conversion of Convertible Securities | shares | 23.22M | 2014-01-01 | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-10-22 | 0001477932-14-005534 |
| us-gaap | StockIssuedDuringPeriodSharesIssuedForServices | Stock Issued During Period, Shares, Issued for Services | shares | 25,000 | 2017-01-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 |
| us-gaap | StockIssuedDuringPeriodSharesNewIssues | Stock Issued During Period, Shares, New Issues | shares | 383,160 | 2011-05-01 | 2011-05-31 | 2012 | Q3 | 10-Q | 2012-11-14 | 0001471242-12-001449 |
| us-gaap | StockIssuedDuringPeriodSharesOther | Stock Issued During Period, Shares, Other | shares | 839,951 | 2011-05-01 | 2011-05-31 | 2012 | Q2 | 10-Q/A | 2012-08-31 | 0001432093-12-000689 |
| us-gaap | StockIssuedDuringPeriodSharesShareBasedCompensation | Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture | shares | 100,000 | 2013-05-01 | 2013-05-30 | 2013 | Q2 | 10-Q | 2013-08-02 | 0001477932-13-003445 |
| us-gaap | StockIssuedDuringPeriodValueAcquisitions | Stock Issued During Period, Value, Acquisitions | USD | 206,600 | 2011-10-01 | 2011-12-31 | 2011 | FY | 10-K | 2012-05-31 | 0001214782-12-000044 |
| us-gaap | StockIssuedDuringPeriodValueIssuedForServices | Stock Issued During Period, Value, Issued for Services | USD | -906 | 2017-01-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 11,480 | 2011-05-01 | 2011-05-31 | 2012 | Q3 | 10-Q | 2012-11-14 | 0001471242-12-001449 |
| us-gaap | StockIssuedDuringPeriodValueOther | Stock Issued During Period, Value, Other | USD | 25,669 | 2011-05-01 | 2011-05-31 | 2012 | Q2 | 10-Q/A | 2012-08-31 | 0001432093-12-000689 |
| us-gaap | StockIssuedDuringPeriodValueShareBasedCompensation | Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture | USD | 1,410 | 2013-05-01 | 2013-05-30 | 2013 | Q2 | 10-Q | 2013-08-02 | 0001477932-13-003445 |
| us-gaap | StockIssuedDuringPeriodValueShareBasedCompensationGross | Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture | USD | 6,000 | 2015-01-01 | 2015-12-31 | 2016 | FY | 10-K | 2017-03-29 | 0001477932-17-001354 |
| us-gaap | ValuationAllowanceAmount | Valuation Allowance, Amount (Deprecated 2013-01-31) | USD | -1.17M | 2012-12-31 | 2012 | FY | 10-K/A | 2014-05-05 | 0001477932-14-002329 | |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 3.74M | 2017-01-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-14 | 0001477932-17-005517 |